Advertisement
Advertisement

HIMS

HIMS logo

Hims & Hers Health, Inc.

20.43
USD
Sponsored
-0.43
-2.09%
Mar 27, 09:32 UTC -4
Open

HIMS Earnings Reports

Positive Surprise Ratio

HIMS beat 15 of 21 last estimates.

71%

Next Report

Date of Next Report
May 04, 2026
Estimate for Q1 26 (Revenue/ EPS)
$628.79M
/
$0.03
Implied change from Q4 25 (Revenue/ EPS)
+1.78%
/
-62.50%
Implied change from Q1 25 (Revenue/ EPS)
+7.30%
/
-85.00%

Hims & Hers Health, Inc. earnings per share and revenue

On Feb 23, 2026, HIMS reported earnings of 0.08 USD per share (EPS) for Q4 25, beating the estimate of 0.04 USD, resulting in a 71.31% surprise. Revenue reached 617.82 million, compared to an expected 631.61 million, with a -2.18% difference. The market reacted with a -0.32% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 10 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 628.79 million USD, implying an decrease of -62.50% EPS, and increase of 1.78% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Heartflow, Inc. Common Stock
Report Date
Mar 18, 2026 For Q4 25
Estimate
-$0.17
Actual
-$0.12
Surprise
+30.31%
logo
Nyxoah SA Ordinary Shares
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.58
Surprise
-5.51%
logo
Insight Molecular Diagnostics Inc. Common Stock
Report Date
Mar 26, 2026 For Q4 25
Estimate
-$0.24
Actual
-$0.27
Surprise
-11.57%
logo
Neuraxis, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.21
Actual
-$0.17
Surprise
+22.48%
logo
HeartSciences Inc. Common Stock
Report Date
Mar 16, 2026 For Q3 26
Estimate
-$0.86
Actual
-$0.63
Surprise
+27.34%
FAQ
For Q4 2025, Hims & Hers Health, Inc. reported EPS of $0.08, beating estimates by 71.31%, and revenue of $617.82M, -2.18% below expectations.
The stock price moved down -0.32%, changed from $15.51 before the earnings release to $15.46 the day after.
The next earning report is scheduled for May 04, 2026.
Based on 10 analysts, Hims & Hers Health, Inc. is expected to report EPS of $0.03 and revenue of $628.79M for Q1 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement